The story · written by gpt-6.1-sol-medium,
The Lords’ medical-cannabis report belongs in 1998. The existing page address retains 1997 for continuity, but the dated event has been corrected from official records.
The parliamentary catalogue says the report was ordered printed on 4 November 1998; the publication announcement is dated 11 November. It says the inquiry began in April. That chronology supersedes the 1997 reference in Suzanne Taylor’s chapter.
The committee recommended urgent trials and transferring cannabis and resin to Schedule 2 for named-patient prescribing. It also supported retaining recreational prohibition. These were recommendations, not an enacted permission for patients.
Taylor’s account remains useful for the differences between patient organisations: the Alliance for Cannabis Therapeutics wanted interim herbal access, while the MS Society prioritised trials. The 1997 conference is now recorded separately. The 2001 follow-up continued the pressure for change.[1][2][3][4]
Listed for context. No score change is recorded for United Kingdom here.
References
- Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis in the UK, 1973–2004Suzanne Taylor · In Cannabis: Global Histories, edited by Lucas Richert, James H. Mills · MIT Press · 2021 · pp. 352–353 (1997 dating superseded by official parliamentary records) · ISBN 9780262366137
- House of Lords — Cannabis: the scientific and medical evidence, Ninth Report (1998)archived
- House of Lords — report publication announcement (11 November 1998)
- House of Lords — Cannabis, Chapter 8: Opinion of the CommitteeParagraphs 8.3, 8.6 and 8.18archived
Checked. The date and the event were compared with a source that was read.